372 related articles for article (PubMed ID: 33613527)
1. Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity.
Munroe ME; Anderson JR; Gross TF; Stunz LL; Bishop GA; James JA
Front Immunol; 2020; 11():606936. PubMed ID: 33613527
[TBL] [Abstract][Full Text] [Related]
2. Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice.
Peters AL; Stunz LL; Meyerholz DK; Mohan C; Bishop GA
J Immunol; 2010 Oct; 185(7):4053-62. PubMed ID: 20810985
[TBL] [Abstract][Full Text] [Related]
3. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments.
Poole BD; Gross T; Maier S; Harley JB; James JA
J Autoimmun; 2008 Dec; 31(4):362-71. PubMed ID: 18849143
[TBL] [Abstract][Full Text] [Related]
4. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies.
Sundar K; Jacques S; Gottlieb P; Villars R; Benito ME; Taylor DK; Spatz LA
J Autoimmun; 2004 Sep; 23(2):127-40. PubMed ID: 15324931
[TBL] [Abstract][Full Text] [Related]
5. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry.
McClain MT; Heinlen LD; Dennis GJ; Roebuck J; Harley JB; James JA
Nat Med; 2005 Jan; 11(1):85-9. PubMed ID: 15619631
[TBL] [Abstract][Full Text] [Related]
6. The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus.
Tu J; Wang X; Geng G; Xue X; Lin X; Zhu X; Sun L
Front Immunol; 2018; 9():187. PubMed ID: 29497417
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
Arcipowski KM; Stunz LL; Graham JP; Kraus ZJ; Vanden Bush TJ; Bishop GA
J Biol Chem; 2011 Mar; 286(12):9948-55. PubMed ID: 21262968
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus.
Poole BD; Scofield RH; Harley JB; James JA
Autoimmunity; 2006 Feb; 39(1):63-70. PubMed ID: 16455583
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus infection induces lupus autoimmunity.
Harley JB; James JA
Bull NYU Hosp Jt Dis; 2006; 64(1-2):45-50. PubMed ID: 17121489
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I.
Sabbatini A; Bombardieri S; Migliorini P
Eur J Immunol; 1993 May; 23(5):1146-52. PubMed ID: 8386666
[TBL] [Abstract][Full Text] [Related]
11. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus.
McClain MT; Poole BD; Bruner BF; Kaufman KM; Harley JB; James JA
Arthritis Rheum; 2006 Jan; 54(1):360-8. PubMed ID: 16385527
[TBL] [Abstract][Full Text] [Related]
12. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity.
Incaprera M; Rindi L; Bazzichi A; Garzelli C
Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD.
Deshmukh US; Sim DL; Dai C; Kannapell CJ; Gaskin F; Rajagopalan G; David CS; Fu SM
J Autoimmun; 2011 Nov; 37(3):254-62. PubMed ID: 21868195
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to an Epstein Barr Virus protein that cross-react with dsDNA have pathogenic potential.
Singh D; Oudit O; Hajtovic S; Sarbaugh D; Salis R; Adebowale T; James J; Spatz LA
Mol Immunol; 2021 Apr; 132():41-52. PubMed ID: 33545624
[TBL] [Abstract][Full Text] [Related]
15. Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.
Csorba K; Schirmbeck LA; Tuncer E; Ribi C; Roux-Lombard P; Chizzolini C; Huynh-Do U; Vanhecke D; Trendelenburg M
Front Immunol; 2019; 10():2619. PubMed ID: 31787984
[TBL] [Abstract][Full Text] [Related]
16. A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice.
James JA; Harley JB
J Immunol; 1998 Jan; 160(1):502-8. PubMed ID: 9552009
[TBL] [Abstract][Full Text] [Related]
17. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1.
McClain MT; Rapp EC; Harley JB; James JA
J Med Virol; 2003 Jun; 70(2):253-7. PubMed ID: 12696112
[TBL] [Abstract][Full Text] [Related]
18. The curiously suspicious: a role for Epstein-Barr virus in lupus.
Harley JB; Harley IT; Guthridge JM; James JA
Lupus; 2006; 15(11):768-77. PubMed ID: 17153849
[TBL] [Abstract][Full Text] [Related]
19. Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture.
Stunz LL; Busch LK; Munroe ME; Sigmund CD; Tygrett LT; Waldschmidt TJ; Bishop GA
Immunity; 2004 Aug; 21(2):255-66. PubMed ID: 15308105
[TBL] [Abstract][Full Text] [Related]
20. Antibodies elicited in response to EBNA-1 may cross-react with dsDNA.
Yadav P; Tran H; Ebegbe R; Gottlieb P; Wei H; Lewis RH; Mumbey-Wafula A; Kaplan A; Kholdarova E; Spatz L
PLoS One; 2011 Jan; 6(1):e14488. PubMed ID: 21245919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
